Ketamine vs. Propofol: Mechanism, Analgesia and Hemodynamic Effects
Ketamine mainly blocks NMDA receptors and provides dissociative anesthesia with analgesia. Propofol enhances GABA-A inhibition and provides sedation or hypnosis, without reliable pain relief. Both can make a patient less responsive, but they get there differently and don’t meet every clinical need in the same way.
Sachi, CRNA
CRNA

In This Article (8 sections)
- What does ketamine block?
- What does propofol do differently?
- How do the useful effects and risks compare?
- Why doesn’t ketamine always maintain blood pressure?
- What would you compare in two patients?
- How would you explain the comparison in an interview?
- Our Final Thoughts
- Explore the induction-agent lessons
For your induction-agent review, give each drug more than a “BP up” or “BP down” label. You can start with the receptor, then work through what that patient needs.
Start with what you need the drug to do. The induction-agent lessons in the CRNA Club clinical library through the seven-day platform trial help you compare awareness, pain, breathing and circulation in a specific patient.
What does ketamine block?
NMDA receptors respond to glutamate, a neurotransmitter that promotes neuronal activity. Ketamine inhibits activity at this receptor-associated ion channel, reducing that excitatory signaling.
That contributes to dissociation, a distinct state of altered awareness and responsiveness. Ketamine also has analgesic effects, meaning pain relief. The effect you want still depends on exposure and clinical use.
Does dissociation mean the airway is protected? No. The ketamine prescribing information warns about respiratory depression, airway complications and hemodynamic changes. Preserved reflexes don’t guarantee freedom from aspiration, obstruction or laryngospasm.
What does propofol do differently?
GABA slows neuronal activity. Propofol enhances its inhibitory action at GABA-A receptors. These are ligand-gated ion channels, so a signal binding the receptor changes ion-channel activity. They aren’t G-protein-coupled receptors.
More inhibitory signaling reduces neuronal activity. Depending on exposure, that produces sedation or hypnosis. It doesn’t reliably treat the painful stimulus itself.
The propofol prescribing information describes hypotension, apnea and airway obstruction among the risks. A patient who becomes unresponsive may still need analgesia, and breathing can become inadequate.
As you review the induction-agent lessons, keep awareness, pain processing and muscle relaxation separate. An effect on one doesn’t automatically tell you what happened to the other two.
How do the useful effects and risks compare?
| Question | Ketamine | Propofol |
|---|---|---|
| Main receptor action | NMDA antagonism | Enhanced GABA-A inhibition |
| Pain relief | Analgesic effects | Not a reliable analgesic |
| Circulation | Sympathetic effects often raise rate and pressure | Vasodilation and cardiovascular depression can lower pressure |
| Breathing and airway | Respiratory depression and airway events remain possible | Exposure-related ventilatory depression and apnea are concerns |
| Recovery | Watch for emergence reactions and other adverse effects | Dose, exposure duration and patient factors affect recovery |
These are expected tendencies. The patient’s reserve, other medications and illness can change what actually happens.
Why doesn’t ketamine always maintain blood pressure?
Its sympathetic effects often support heart rate and pressure. But the patient has to be able to generate that response. Severe illness, the dose and other medications can alter it.
Hypotension and cardiac decompensation are still possible, especially in a vulnerable patient. You need a cardiovascular assessment and preparation for deterioration whichever agent is chosen.
This is where a one-line memory aid can mislead you. “Ketamine often raises BP” describes a tendency. It doesn’t promise protection from induction hypotension.
What would you compare in two patients?
In these fictional examples, Patient A needs rapid, adjustable hypnosis during an intensely stimulating procedure. Propofol’s titratability is relevant. You still have to ask how pain will be treated, how ventilation will be supported and how much cardiovascular reserve the patient has.
Patient B has substantial pain and concern for hypotension. Ketamine’s analgesia and sympathetic effects are relevant. Now ask about airway risk, why pressure is low and whether the expected sympathetic response is likely to be available.
Neither short description settles the entire drug choice. Work through the useful effect and the complication you need to anticipate.
How would you explain the comparison in an interview?
Start with the receptor and follow it into the patient. Propofol enhances GABA-A inhibition, producing hypnosis without reliable analgesia. Ketamine mainly blocks NMDA signaling, producing dissociative anesthesia and analgesia.
Then compare breathing, airway needs and hemodynamics. Add the pain plan and expected recovery. That tells the interviewer why one effect fits the goal, while showing what you would watch after giving the drug.
Our Final Thoughts
Try the comparison with one patient variable changed. Explain pain relief and hypnosis first, then return to breathing and circulation. It’s fine to slow down at the mechanism you can’t explain yet. That’s the part to review before trying another case.
Explore the induction-agent lessons
The induction-agent lessons in the seven-day CRNA Club platform trial can support that review. Change blood pressure, pain or ventilation needs in the example and talk through your reasoning again.


